Excellent post Sean, If our drug continues to be as

New Post Public Reply Private Reply Replies (5) Message Board
SizzlChest sean007 #88957
955
Excellent post Sean,

If our drug continues to be as effective as we already believe it to be on so many indications, this little molecule changes medicine moving forward. BP is well aware of this.

If anyone thinks for one second that several large BP companies combined are willing to lose 100s of billions posssibly approaching a trillion dollars in revenues over the next 12 years from lost sales due to LL, are not monitoring this board, then that person is foolish.

They arleady pay people to bash the stock around the clock to create confusion, anxiety, and to get us to question our position as longs and keep new investors on the sideline.

They already fund short-sellers coffers to keep the price down to prevent uplisting and media attention. They pay hack attorneys to create a smear campaign to dissuade potential investors. All of this in an attempt to make a buyout more palatable at far less than what this company is worth if it were on a level playing field.

They pull strings with employees at the FDA (jobs, trips, consulting fees), fund the FDA directly, and spend hundreds of millions on lobbyist to keep sales flowing and competition minimized.

They are monitoring this board. They are studying every point made, every little argument we have, every insecurity we list, and they are and will continue to use it against us.

We are not talking about two competing locally owned pizza joints in a little podunk town... We are talking about companies that shape the world in which we live.

I appreciate discussion about our drug and the indications. I do not appreciate telling the enemy our individual investment plans and our perceived weaknesses of the company we own.

All of the 'I would take this price' and 'Nader sucks' stuff ultimately hurts any possibly stock price gains. Nader said 3 digits, he's our captain, end of story.

If anyone is happy at 20$ then sell when we hit 20$... 30$ wait for 30$, 40-50 good on you sell it all and retire... But believe me when Nader said 3 digits that is what he meant! They better come with at least 3 digits or keep spending billions to hold us down.

Also, here's another one for the Nader bashers to think about... If you had the vision for CYDY, risk your families money on it, worked 18+ hours a day jumping through hoops and dealing with a stacked deck, trying to keep investors optimistic in the face of dirty BP tricks, trying to get the best possible financing under the circumstances, having people personally attack you online incessantly, and all the while knowing the board of directors could shit can you at any moment before you saw the fruits of your labor... How much would you pay yourself while you had the chance????

Don't reply, I already know the answer.

We have a gold mine. Keep the location information to yourself, or at least wait until it starts producing gold to tell everyone what you think its worth. And stop with the costant bickering, while it is nice to vent, how much did it end up hitting you in the pocket book???

There are a few things right now that CYDY can/is doing to generate sales and get approvals. I will not share what I believe is happening because I will not give the enemy information to use against us. I hope others are in agreement with this.


GLTA longs!!! Our day is approaching, hang in there


CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 248

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 34

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 497

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 17

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 336

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 81

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 62

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 83

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 281

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 493

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

FPI Earnings Preview: Traders Eye EPS and Guidance Impact

Updated Category News Views 158

Farmland Partners (NYSE:FPI) is prepped to drop its quarterly earnings on February 18, 2026, and you better believe traders are already sweating over it. Analysts are throwing out estimates pegging the earnings per share (EPS) at $0.19—now, that's not exactly a home run but it's enough to keep eyes glued to the screens as we await the news. The buzz in the air is thick;...

Continue Reading
Reviva Pharmaceuticals Engages Investors at 2025 Summit

Updated Category News Views 312

Reviva Pharmaceuticals Attending the 2025 Investor Healthcare Summit Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is a leader in the biopharmaceutical industry, committed to developing cutting-edge therapies that cater to unmet medical needs. This January, Reviva will have an influential presence at the upcoming Lytham Partners 2025 Investor Healthcare Summit....

Continue Reading
Genpact's Q1 2025 Financial Highlights and Future Outlook

Updated Category News Views 886

Financial Performance Overview for Genpact Genpact Limited (NYSE: G) has reported outstanding net revenues of $1.215 billion for the first quarter of 2025, reflecting a robust growth rate of 7.4% year-over-year, or 8.3% when adjusted for constant currency fluctuations. This growth has been fueled by an impressive performance in its Data-Tech-AI segment, which generated...

Continue Reading
Multinational Investments: How to Reach More Countries

Updated Category Investing Views 706

Global expansion has become a strategic priority for companies seeking long-term growth. Markets mature, local competition intensifies, and consumer expectations evolve quickly. As a result, multinational investments are no longer reserved for massive corporations. Mid-sized and even smaller firms are exploring foreign markets to diversify revenue and increase resilience....

Continue Reading
Nobu Hospitality Unveils Luxury Residential Options in Kraków

Updated Category News Views 126

Nobu Hospitality Expands Its Luxury Footprint Nobu Hospitality is a name synonymous with luxury and refinement in the hospitality industry, expanding its prestigious brand into new territories. One of its latest ventures takes a significant leap into a magnificent city rich in history—Kraków. This development marks a notable milestone as it is Nobu's first residential...

Continue Reading